Daunomycin (NSC-82151) in the treatment of metastatic neuroblastoma.
D000293:Adolescent; D000740:Anemia / Q000139:chemically induced; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000139:chemically induced; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*
D003630:Daunorubicin